Literature DB >> 19767224

High prevalence of structural heart disease in children with cblC-type methylmalonic aciduria and homocystinuria.

Laurie E Profitlich1, Brian Kirmse, Melissa P Wasserstein, George A Diaz, Shubhika Srivastava.   

Abstract

OBJECTIVE: To characterize the frequency and nature of cardiovascular defects in patients with CblC-type methylmalonic aciduria and homocystinuria (cblC), an inborn error of cobalamin (vitamin B12) metabolism resulting in accumulation of methylmalonic acid and homocysteine. STUDY
DESIGN: A retrospective observational study was conducted investigating 10 patients with cblC ranging in age from 2 weeks to 24 years (mean 4.4 years +/- 7.5 years, median 0.6 years). All patients underwent a complete 2-D echocardiogram including quantitative assessment of left ventricular systolic function.
RESULTS: Structural heart defects were detected in 50% of patients with cblC. Heart defects included left ventricular (LV) non-compaction (3), secundum atrial septal defect (2), muscular ventricular septal defect (1), dysplastic pulmonary valve without pulmonary stenosis (1) and mitral valve prolapse with mild mitral regurgitation (1). One patient had resolved cor pulmonale and right heart failure secondary to pulmonary embolism. All patients had quantitatively normal LV systolic function.
CONCLUSIONS: Diverse and clinically significant structural heart defects appear to be highly prevalent in cblC, perhaps due to abnormal DNA and histone methylation during embryogenesis. The specific cardiac defects detected in our cohort were variable, and studies with a larger number of patients are needed to establish which forms are most common. Routine and periodic cardiovascular evaluation may be indicated in patients with cblC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19767224     DOI: 10.1016/j.ymgme.2009.07.017

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  26 in total

1.  Reversible pulmonary arterial hypertension in cobalamin-dependent cobalamin C disease due to a novel mutation in the MMACHC gene.

Authors:  Mehmet Gündüz; Filiz Ekici; Eda Özaydın; Serdar Ceylaner; Belen Perez
Journal:  Eur J Pediatr       Date:  2014-05-24       Impact factor: 3.183

2.  Noncompaction of the ventricular myocardium and hydrops fetalis in cobalamin C disease.

Authors:  Pranoot Tanpaiboon; Jennifer L Sloan; Patrick F Callahan; Dorothea McAreavey; P Suzanne Hart; Uta Lichter-Konecki; Dina Zand; Charles P Venditti
Journal:  JIMD Rep       Date:  2012-12-29

3.  Co-occurrence of the Poland sequence in a patient with the cobalamin C defect: more than just a coincidence?

Authors:  James D Weisfeld-Adams; Peter R Baker
Journal:  J Inherit Metab Dis       Date:  2014-11-12       Impact factor: 4.982

4.  Thrombotic microangiopathy and breastfeeding: where is the link? Answers.

Authors:  Jean Daniel Delbet; Tim Ulinski
Journal:  Pediatr Nephrol       Date:  2017-08-15       Impact factor: 3.714

5.  Milder clinical and biochemical phenotypes associated with the c.482G>A (p.Arg161Gln) pathogenic variant in cobalamin C disease: Implications for management and screening.

Authors:  Mohammed Almannai; Ronit Marom; Kristian Divin; Fernando Scaglia; V Reid Sutton; William J Craigen; Brendan Lee; Lindsay C Burrage; Brett H Graham
Journal:  Mol Genet Metab       Date:  2017-06-29       Impact factor: 4.797

Review 6.  Combined methylmalonic acidemia and homocystinuria, cblC type. II. Complications, pathophysiology, and outcomes.

Authors:  Nuria Carrillo-Carrasco; Charles P Venditti
Journal:  J Inherit Metab Dis       Date:  2011-07-12       Impact factor: 4.982

Review 7.  Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management.

Authors:  Nuria Carrillo-Carrasco; Randy J Chandler; Charles P Venditti
Journal:  J Inherit Metab Dis       Date:  2011-07-12       Impact factor: 4.982

8.  To ascertain the utility of urinary methyl malonic Acid as a potential marker of ischemic heart failure.

Authors:  Sonal Pruthi; Ankur Singh; Chandrawati Kumari; Ashish Goel; Seema Kapoor
Journal:  J Clin Diagn Res       Date:  2014-09-20

9.  The vitamin B12 processing enzyme, mmachc, is essential for zebrafish survival, growth and retinal morphology.

Authors:  Jennifer L Sloan; Nathan P Achilly; Madeline L Arnold; Jerrel L Catlett; Trevor Blake; Kevin Bishop; Marypat Jones; Ursula Harper; Milton A English; Stacie Anderson; Niraj S Trivedi; Abdel Elkahloun; Victoria Hoffmann; Brian P Brooks; Raman Sood; Charles P Venditti
Journal:  Hum Mol Genet       Date:  2020-08-03       Impact factor: 6.150

10.  Clinical presentation and outcome in a series of 88 patients with the cblC defect.

Authors:  Sabine Fischer; Martina Huemer; Matthias Baumgartner; Federica Deodato; Diana Ballhausen; Avihu Boneh; Alberto B Burlina; Roberto Cerone; Paula Garcia; Gülden Gökçay; Stephanie Grünewald; Johannes Häberle; Jaak Jaeken; David Ketteridge; Martin Lindner; Hanna Mandel; Diego Martinelli; Esmeralda G Martins; Karl O Schwab; Sarah C Gruenert; Bernd C Schwahn; László Sztriha; Maren Tomaske; Friedrich Trefz; Laura Vilarinho; David S Rosenblatt; Brian Fowler; Carlo Dionisi-Vici
Journal:  J Inherit Metab Dis       Date:  2014-03-06       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.